Expression of interleukin 17 and IgE, and its significance in patients with bronchial asthma

To investigate the expression and its significance of interleutin-17 (IL-17) and immunoglobulin E (IgE) in patients with bronchial asthma, sixty adult patients with bronchial asthma and 30 healthy human control were sequentially enrolled in this study. The production of IL-17 was measured by enzyme-linked immunosorbent assay (ELISA) and fluorescent quantitative polymerase chain reaction (qPCR), respectively. The correlation between expression of IgE and IL-17 was analyzed. It was found that IL-17 was significantly up-regulated in bronchial asthma in comparison to the health control on mRNA level, and serum levels of IL-17 and IgE in bronchial asthma were significantly higher than those in health control, respectively (P < 0. 001). Significant positive correlation in bronchial asthma were found between expression of IL-17 and IgE (r = 0.7082, P = 0.0418). The present study implied that expressions of IL-17 and IgE play an important role in the development of bronchial asthma.   Key words: Bronchial asthma, immunoglobulin E, interleukin-17, enzyme-linked immunosorbent assay (ELISA).